Bioscience Biotechnology Research Communications

An Open Access International Journal

P-ISSN: 0974-6455 E-ISSN: 2321-4007

Bioscience Biotechnology Research Communications

An Open Access International Journal

Satyabrata Nanda

MS Swaminathan School of Agriculture, Centurion University of Technology and Management, Odisha, India

DOI:

Article Publishing History

Received: 07/10/2020

Accepted After Revision: 29/12/2020

ABSTRACT:

The current pandemic of the Corona virus disease (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has urged for the invention and implementation of effective drugs and vaccines to mitigate the adversity worldwide. Numerable studies are going on to identify and evaluate the efficacy of several synthetic drugs and vaccines. In this scenario, identification and use of plant-derived biomolecules against SARS-CoV-2 could be highly beneficial. Furthermore, upscale production of such plant metabolites and plant-based vaccines can help in controlling the pandemic. Several previous studies have reported the success of plant-based traditional medicines in immunity enhancement and decreasing viral loads. Thus, in depth researches involving the phytochemicals could reveal their roles and level of efficacy against SARS-CoV-2. Considering the present scenario, this review article presents the perspectives of using the phytochemicals in mitigating SARS-CoV-2, and the possible evolution of these phytochemicals into phytomedicines.

KEYWORDS:

Phytochemicals, Secondary metabolites, SARS-CoV-2, COVID-19.

Download this article as:

Copy the following to cite this article:


Copy the following to cite this URL: